Hunter Outcome Survey: A Global Multi-Center Long-Term Observational Registry of Patients with Hunter Syndrome

Brief description of study

The purpose of the Hunter Outcome Survey (HOS) is to monitor the long-term safety and effectiveness of enzyme replacement therapy (ERT) with Elaprase in patients with Hunter syndrome and to gather more information about the disease itself regardless of whether patients are receiving treatment or not. There are many unanswered questions concerning Hunter syndrome and the progression of the disease. The HOS provides a platform for the collection of long-term clinical data from patients affected by the disease in order to understand the disease better and to hopefully aid in improving the way affected patients are cared for.

Clinical Study Identifier: 06-916 Identifier: NCT03292887
Other Investigator: Berrin Monteleone.

If you are registered as a volunteer, please log in to contact the study team/express interest in this study.

Contact the research team to learn more about this study.

By clicking "Contact Research Team", your contact information will be sent securely to the research staff associated with the study. You will also receive a copy of this email in your inbox, as well as other notifications to determine your participation status in the study.